Accelerate Diagnostics announces launch of proposed public offering

Accelerate Diagnostics ( NASDAQ: AXDX ) on Tuesday announced the launch of a proposed underwritten public offering of 4,500,000 units, each consisting of one share of common stock and one warrant to purchase one share of common stock, or for certain investors, pre funded units in lieu thereof, with each pre funded unit consisting of one pre funded warrant to purchase one share of common stock and one warrant to purchase one share of common stock.

The company expects to grant the underwriters a 30 day option to purchase up to an additional 675,000 shares of common stock and/or additional warrants to purchase up to 675,000 shares of common stock, in any combination thereof, at the public offering price. Source: Press Release More on Accelerate Diagnostics Seeking Alpha’s Quant Rating on Accelerate Diagnostics Historical earnings data for Accelerate Diagnostics Financial information for Accelerate Diagnostics.